Columbia Research Enhanced Value ETF (NYSEARCA:REVS) Sees Large Decline in Short Interest

Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Get Free Report) was the recipient of a significant decrease in short interest in the month of October. As of October 30th, there was short interest totaling 23,659 shares, a decrease of 64.2% from the October 15th total of 66,171 shares. Based on an average trading volume of 52,754 shares, the short-interest ratio is currently 0.4 days. Approximately 0.2% of the shares of the stock are sold short.

Hedge Funds Weigh In On Columbia Research Enhanced Value ETF

Institutional investors and hedge funds have recently made changes to their positions in the stock. First Interstate Bank acquired a new position in Columbia Research Enhanced Value ETF during the third quarter worth about $3,602,000. Inscription Capital LLC increased its holdings in Columbia Research Enhanced Value ETF by 43.3% in the third quarter. Inscription Capital LLC now owns 56,081 shares of the company’s stock valued at $1,840,000 after buying an additional 16,945 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in shares of Columbia Research Enhanced Value ETF by 13.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 361,667 shares of the company’s stock valued at $11,371,000 after acquiring an additional 44,147 shares during the period. Essex Financial Services Inc. acquired a new stake in shares of Columbia Research Enhanced Value ETF during the 3rd quarter valued at approximately $2,335,000. Finally, Harbour Investments Inc. acquired a new stake in shares of Columbia Research Enhanced Value ETF during the 3rd quarter valued at approximately $86,000.

Columbia Research Enhanced Value ETF Stock Performance

NYSEARCA:REVS traded down $0.25 during trading hours on Monday, hitting $34.49. The company’s stock had a trading volume of 34,346 shares, compared to its average volume of 50,081. The business’s 50-day moving average is $33.84 and its two-hundred day moving average is $31.82. The company has a market capitalization of $403.53 million, a PE ratio of 18.11 and a beta of 0.79. Columbia Research Enhanced Value ETF has a 52-week low of $27.24 and a 52-week high of $35.44.

About Columbia Research Enhanced Value ETF

(Get Free Report)

The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.

See Also

Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.